EUVIMEDEUVIMED entdecken
Open Access

Afucosylated broadly neutralizing antibodies targeting the HIV envelope elicit enhanced NK-cell–mediated cytotoxicity against HIV-infected CD4+ T-cell and macrophage targets

Olivia Wilhelm, Christine Jordan, Hans Kek, Morgane M Brunton-O'Sullivan, Laura Rikard-Bell, Pradhipa Ramanathan, Amy W Chung, Pantelis Poumbourios, Bruce D Wines, Anthony Jaworowski, Anna C Hearps iD

Journal of Leukocyte Biology · 07.05.2025 · 117 (5)

DOI: 10.1093/jleuko/qiaf033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, online erschienen am 15.03.2025. Verfasst von Olivia Wilhelm und 10 weiteren Autor:innen. Beteiligte Einrichtung: Life Sciences Discipline, Burnet Institute, GPO Box 284, Melbourne, VIC 3004, Australia. Hauptthemen laut MEDLINE: Macrophages, CD4-Positive T-Lymphocytes, HIV Infections, Killer Cells, Natural. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Foundation for AIDS Research, National Health and Medical Research Council of Australia, NIH AIDS Reagent Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enhancement of antibody-dependent cellular cytotoxicity is a promising adjunct approach to achieve HIV control in the absence of antiretroviral therapy but requires the development of potent antibody-dependent cellular cytotoxicity–eliciting antibodies that can recognize diverse HIV-infected cell types. A panel of broadly neutralizing antibodies targeting the HIV envelope was identified that specifically binds both HIV-infected CD4+ T cells and monocyte-derived macrophages. Afucosylated versions of these broadly neutralizing antibodies containing ≈30% less core fucose were generated and elicited a significant increase in antibody-dependent cellular cytotoxicity responses from natural killer cells against HIV-infected T-cell and monocyte-derived macrophage targets. Afucosylation did not alter virus neutralization or cell-binding activity of these broadly neutralizing antibodies. Afucosylation modification of broadly neutralizing antibody Fc regions is thus a promising strategy to enhance Fc-mediated activity against both T-cell and macrophage targets in vivo, which may be employed to heighten the therapeutic potential of antibody-based immunotherapy approaches for drug-free HIV control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesCD4-Positive T-LymphocytesHIV InfectionsKiller Cells, NaturalAntibody-Dependent Cell CytotoxicityHIV-1HIV AntibodiesAntibodies, Neutralizingenv Gene Products, Human Immunodeficiency VirusHumansBroadly Neutralizing AntibodiesFucoseGlycosylation

Stichwörter der Autor:innen

HIV cureantibody afucosylationantibody-dependent cellular cytotoxicitynatural killer cell

Substanzen

HIV AntibodiesAntibodies, Neutralizingenv Gene Products, Human Immunodeficiency VirusBroadly Neutralizing AntibodiesFucose

Autor:innen und Institutionen

  • Life Sciences Discipline, Burnet Institute, GPO Box 284, Melbourne, VIC 3004, Australia.
  • Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, 792 Elizabeth St, Melbourne, VIC 3000, Australia.
  • Department of Immunology, School of Translational Medicine, Monash University, Level 6, 99 Commercial Rd, Melbourne, VIC 3004, Australia.
  • Department of Microbiology, Monash University, 19 Innovation Walk, Clayton, VIC 3800, Australia.
  • Department of Infectious Diseases, Monash University, Level 2, 85 Commercial Rd, Melbourne, VIC 3004, Australia.
  • School of Health and Biomedical Sciences, RMIT University, Plenty Rd, Bundoora, VIC 3083, Australia.

ORCID-Profile: Anna C Hearps

Förderung

  • American Foundation for AIDS Research
  • National Health and Medical Research Council of Australia
  • NIH AIDS Reagent Program
  • Division of AIDS
  • NIAID
  • NIH
  • Polyclonal Anti-Human Immunodeficiency Virus Immune Globulin
  • 8E5 HIV-infected T cell line

Zitieren

APA

Wilhelm, O., Jordan, C., Kek, H., Brunton-O'Sullivan, M. M., Rikard-Bell, L., Ramanathan, P., Chung, A. W., Poumbourios, P., Wines, B. D., Jaworowski, A., & Hearps, A. C. (2025). Afucosylated broadly neutralizing antibodies targeting the HIV envelope elicit enhanced NK-cell–mediated cytotoxicity against HIV-infected CD4+ T-cell and macrophage targets. Journal of Leukocyte Biology, 117(5). https://doi.org/10.1093/jleuko/qiaf033

Vancouver

Wilhelm O, Jordan C, Kek H, Brunton-O'Sullivan MM, Rikard-Bell L, Ramanathan P, et al. Afucosylated broadly neutralizing antibodies targeting the HIV envelope elicit enhanced NK-cell–mediated cytotoxicity against HIV-infected CD4+ T-cell and macrophage targets. Journal of Leukocyte Biology. 2025;117(5). doi:10.1093/jleuko/qiaf033

BibTeX
@article{Wilhelm2025,
  author = {Wilhelm, Olivia and Jordan, Christine and Kek, Hans and Brunton-O'Sullivan, Morgane M and Rikard-Bell, Laura and Ramanathan, Pradhipa and Chung, Amy W and Poumbourios, Pantelis and Wines, Bruce D and Jaworowski, Anthony and Hearps, Anna C},
  title = {Afucosylated broadly neutralizing antibodies targeting the HIV envelope elicit enhanced NK-cell–mediated cytotoxicity against HIV-infected CD4+ T-cell and macrophage targets},
  journal = {Journal of Leukocyte Biology},
  year = {2025},
  volume = {117},
  number = {5},
  doi = {10.1093/jleuko/qiaf033}
}
Kostenlos starten →